Cargando...
Pre-clinical development of a neutral, estrogen receptor-targeted, tridentate (99m)Tc(I) estradiol pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers
Breast and endometrial cancers are the most common invasive malignancies in women with more than 217,000 new diagnoses per year in the United States. These cancers are often classified into two subtypes based upon the expression of the classical estrogen receptor (ERα). In this study, we describe a...
Gardado en:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2008
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2435083/ https://ncbi.nlm.nih.gov/pubmed/18483091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.107.048546 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|